Founded in 2002, Chimerix is a privately held biotechnology company that creates and develops orally available medicines from bioactive molecules. Its applications of proprietary technology enhance oral availability, stabilize drug in plasma and facilitates the delivery of drugs into targeted tissues. Chimerix offers drugs that can be modified to improve dosing parameters, broaden therapeutic applications and decrease the risk of adverse reactions. Its technology also enables discovery of new drugs from molecules with chemical properties that would otherwise be unsuitable for pharmaceutical development. In addition, Chimerix applies its technology towards discovery and the development of oral drugs for the treatment of smallpox, drug-resistant HIV infection and viral hepatitis. The company is located in Durham, N.C.
Payment Methods
MASTERCARDVISACHECKALL MAJOR CREDIT CARDSDISCOVERAMEX